We seed biomedical innovation

and drug discovery in oncology, autoimmunity, and infectious diseases

We seed biomedical innovation

and drug discovery in oncology, autoimmunity, and infectious diseases

Unlock deep immune insights and accelerate your discovery with T-FINDER.

T-FINDER – T cell Functional Identification and (Neo)-antigen Discovery of Epitopes and Receptors

Utilize our T-FINDER research platform to gain valuable insights while searching for your next solution. We specialize in a vital and intricate aspect of the human adaptive immune system: T lymphocytes. Our innovative, patent-pending platform is made up of three key components: the T-cell reporter construct, the Antigen-Presenting Cell construct, and the Phenotypic Screening Platform.

How can we support your research and development?

Profiling
Discovery

The T-FINDER platform is designed to functionally identify and map cognate epitopes to human T cell receptors (TCRs) with high speed and accuracy. It utilizes physiological antigen processing and T-cell activation processes.

T-finder Platform Clinically Tested Scientifically Tested Scientifically Tested Scientifically Tested

Each T cell receptor (TCR) needs
T-Finder helps identify these pairs, making it easier to design new treatments, especially for cancer.

T-Finder helps identify these pairs, making it easier to design new treatments, especially for cancer.

Offers flexibility for multiple applications in immunotherapy.

Can determine the ligand for a given TCR or vice versa, creating a database of receptor-ligand pairs.

The science behind T-FINDER

determined to solve the biggest biomedical research challenges

  • AI-Powered Tracking

Including technical specifications and
application areas.

  • AI-Powered Tracking

Unlock personalized insights with cutting-edge AI technology, designed to track and improve brain health in real-time.

Our Mission

A better way to science by BioMed X

“

By exploring new biology in major human disease areas, we enable our partners to take an active role in seeding biomedical innovation for the benefit of patients.